Guselkumab Safe, Efficient in Biologic-Naïve Patients with Active Psoriatic Arthritis
ACR Annual Meeting: In patients with active psoriatic arthritis, who are biologic-naïve, guselkumab (Tremfya, Janssen) improved joint and skin symptoms, physical function, quality of life, and resolved enthesitis and dactylitis, according to a study presented at annual meeting of the American College of Rheumatology in Atlanta on November 12.